Ardelyx, Inc. (ARDX)
6.555
+0.80
(+14.00%)
USD |
NASDAQ |
Feb 24, 16:00
6.53
-0.02
(-0.38%)
After-Hours: 18:09
Ardelyx EPS Diluted (Quarterly) : -0.0017 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.805 |
| MannKind Corp. | 0.0256 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| PTC Therapeutics, Inc. | -1.673 |
| Fate Therapeutics, Inc. | -0.271 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.407M |
| Revenue (Quarterly) | 125.22M |
| Total Expenses (Quarterly) | 125.62M |
| Enterprise Value | 1.340B |
| Gross Profit Margin (Quarterly) | 90.60% |
| Profit Margin (Quarterly) | -0.32% |
| Earnings Yield | -3.93% |
| Normalized Earnings Yield | -3.930 |